SCIENTURE HOLDINGS, INC. Debt Instrument, Face Amount
SCIENTURE HOLDINGS, INC. (SCNX) had Debt Instrument, Face Amount of $4.00 million as of 2026-02-12, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2026-08-13
- 2026-02-12: Debt Instrument, Face Amount $4.00M.
- 2026-01-15: Debt Instrument, Face Amount $1.50M.
- 2021-09-30: Debt Instrument, Face Amount $630.00K.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2026-02-12 | $4.00M 10-Q · filed 2026-08-13 |
| 2026-01-15 | $1.50M 10-Q · filed 2026-08-13 |
| 2021-09-30 | $630.00K 10-Q · filed 2024-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |